OCX

Actualités OncoCyte

Nom Action Symbole Action Marché Type
OncoCyte Corporation OCX AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,0% 3,72 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,72 3,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/1/202323:19EDGARStatement of Changes in Beneficial Ownership (4)
19/1/202323:17EDGARStatement of Changes in Beneficial Ownership (4)
28/12/202200:48EDGARStatement of Changes in Beneficial Ownership (4)
21/12/202212:06EDGARCurrent Report Filing (8-k)
20/12/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
20/12/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
05/12/202222:07EDGARCurrent Report Filing (8-k)
25/11/202212:01EDGARStatement of Ownership (sc 13g)
10/11/202222:50EDGARQuarterly Report (10-q)
10/11/202222:45EDGARCurrent Report Filing (8-k)
09/11/202222:08EDGARCurrent Report Filing (8-k)
22/9/202223:39EDGARInitial Statement of Beneficial Ownership (3)
19/8/202214:01EDGARStatement of Changes in Beneficial Ownership (4)
18/8/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
12/8/202212:07EDGARQuarterly Report (10-q)
08/8/202222:29EDGARInitial Statement of Beneficial Ownership (3)
03/8/202222:06EDGARCurrent Report Filing (8-k)
28/7/202223:07EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
21/7/202222:06EDGARCurrent Report Filing (8-k)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
19/7/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
15/7/202214:02EDGARCurrent Report Filing (8-k)
29/6/202201:46EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
08/6/202222:06EDGARProxy Statement (definitive) (def 14a)
26/5/202222:15EDGARProxy Statement - Notice of Shareholders Meeting..
19/5/202223:59EDGARStatement of Changes in Beneficial Ownership (4)
12/5/202222:32EDGARQuarterly Report (10-q)
11/5/202222:12EDGARCurrent Report Filing (8-k)
09/5/202221:25EDGARStatement of Ownership (sc 13g)
02/5/202222:06EDGARAmended Annual Report (10-k/a)
29/4/202222:53EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
19/4/202222:01EDGARCurrent Report Filing (8-k)
18/4/202215:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
16/4/202200:14EDGARStatement of Changes in Beneficial Ownership (4)
15/4/202223:22EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
13/4/202223:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
13/4/202223:09EDGARCurrent Report Filing (8-k)
15/3/202221:20EDGARStatement of Changes in Beneficial Ownership (4)
14/3/202211:07EDGARCurrent Report Filing (8-k)
11/3/202223:19EDGARAnnual Report (10-k)
04/2/202222:16EDGARStatement of Ownership (sc 13g)
Dernières Valeurs Consultées
AMEX
OCX
OncoCyte
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20230128 19:01:06